143 related articles for article (PubMed ID: 643394)
1. In vivo and in vitro response of human branched chain alpha-ketoacid dehydrogenase to thiamine and thiamine pyrophosphate.
Danner DJ; Wheeler FB; Lemmon SK; Elsas LJ
Pediatr Res; 1978 Mar; 12(3):235-8. PubMed ID: 643394
[No Abstract] [Full Text] [Related]
2. Thiamine response in maple syrup urine disease.
Fernhoff PM; Lubitz D; Danner DJ; Dembure PP; Schwartz HP; Hillman R; Bier DM; Elsas LJ
Pediatr Res; 1985 Oct; 19(10):1011-6. PubMed ID: 3903643
[TBL] [Abstract][Full Text] [Related]
3. The role of thiamin in maple syrup urine disease.
Elsas LJ; Danner DJ
Ann N Y Acad Sci; 1982; 378():404-21. PubMed ID: 7044230
[No Abstract] [Full Text] [Related]
4. Substrate specificity and stabilization by thiamine pyrophosphate of rat liver branched chain alpha-ketoacid dehydrogenase.
Danner DJ; Lemmon SK; Elsas LJ
Biochem Med; 1978 Feb; 19(1):27-38. PubMed ID: 203270
[No Abstract] [Full Text] [Related]
5. Thiamin-responsive maple-syrup-urine disease: decreased affinity of the mutant branched-chain alpha-keto acid dehydrogenase for alpha-ketoisovalerate and thiamin pyrophosphate.
Chuang DT; Ku LS; Cox RP
Proc Natl Acad Sci U S A; 1982 May; 79(10):3300-4. PubMed ID: 6954481
[TBL] [Abstract][Full Text] [Related]
6. Stabilization of mammalian liver branched-chain alpha-ketoacid dehydrogenase by thiamin pyrophosphate.
Danner DJ; Lemmon SK; Elsas LJ
Arch Biochem Biophys; 1980 Jun; 202(1):23-8. PubMed ID: 7396533
[No Abstract] [Full Text] [Related]
7. Sequence of the E1 alpha subunit of branched-chain alpha-ketoacid dehydrogenase in two patients with thiamine-responsive maple syrup urine disease.
Zhang B; Wappner RS; Brandt IK; Harris RA; Crabb DW
Am J Hum Genet; 1990 Apr; 46(4):843-6. PubMed ID: 2316528
[TBL] [Abstract][Full Text] [Related]
8. Reversion of the maple syrup urine disease phenotype of impaired branched chain alpha-ketoacid dehydrogenase complex activity in fibroblasts from an affected child.
Litwer S; Herring WJ; Danner DJ
J Biol Chem; 1989 Sep; 264(25):14597-600. PubMed ID: 2768232
[TBL] [Abstract][Full Text] [Related]
9. Maple syrup urine disease in a Bedouin tribe: pre- and postnatal diagnosis.
Potashnik R; Carmi R; Sofer S; Bashan N; Abeliovich D
Isr J Med Sci; 1987 Aug; 23(8):886-9. PubMed ID: 3679791
[TBL] [Abstract][Full Text] [Related]
10. Branched-chain alpha-keto acids isolated as oxime derivatives: relationship to the corresponding hydroxy acids and amino acids in maple syrup urine disease.
Lancaster G; Mamer OA; Scriver CR
Metabolism; 1974 Mar; 23(3):257-65. PubMed ID: 4813956
[No Abstract] [Full Text] [Related]
11. Activation of branched-chain alpha-ketoacid dehydrogenase complex by alpha-chloroisocaproate in normal and enzyme-deficient fibroblasts.
Toshima K; Kuroda Y; Yokota I; Naito E; Ito M; Watanabe T; Takeda E; Miyao M
Clin Chim Acta; 1985 Apr; 147(2):103-8. PubMed ID: 3987057
[TBL] [Abstract][Full Text] [Related]
12. Direct physical evidence for stabilization of branched-chain alpha-ketoacid dehydrogenase by thiamin pyrophosphate.
Heffelfinger SC; Sewell ET; Elsas LJ; Danner DJ
Am J Hum Genet; 1984 Jul; 36(4):802-7. PubMed ID: 6475955
[TBL] [Abstract][Full Text] [Related]
13. Maple syrup urine disease: analysis of branched chain ketoacid decarboxylation in cultured fibroblasts.
Wendel U; Wentrup H; Rüdiger HW
Pediatr Res; 1975 Sep; 9(9):709-17. PubMed ID: 1202420
[TBL] [Abstract][Full Text] [Related]
14. Classical maple syrup urine disease: cofactor resistance.
Elsas LJ; Pask BA; Wheeler FB; Perl DP; Truster S
Metabolism; 1972 Oct; 21(10):929-44. PubMed ID: 4342010
[No Abstract] [Full Text] [Related]
15. Maple syrup urine disease: domain structure, mutations and exon skipping in the dihydrolipoyl transacylase (E2) component of the branched-chain alpha-keto acid dehydrogenase complex.
Chuang DT; Fisher CW; Lau KS; Griffin TA; Wynn RM; Cox RP
Mol Biol Med; 1991 Feb; 8(1):49-63. PubMed ID: 1943690
[TBL] [Abstract][Full Text] [Related]
16. Altered kinetic properties of the branched-chain alpha-keto acid dehydrogenase complex due to mutation of the beta-subunit of the branched-chain alpha-keto acid decarboxylase (E1) component in lymphoblastoid cells derived from patients with maple syrup urine disease.
Indo Y; Kitano A; Endo F; Akaboshi I; Matsuda I
J Clin Invest; 1987 Jul; 80(1):63-70. PubMed ID: 3597778
[TBL] [Abstract][Full Text] [Related]
17. A nonsense mutation (R242X) in the branched-chain alpha-keto acid dehydrogenase E1alpha subunit gene (BCKDHA) as a cause of maple syrup urine disease. Mutations in brief no. 160. Online.
Chinsky J; Appel M; Almashanu S; Costeas P; Ambulos N; Carmi R
Hum Mutat; 1998; 12(2):136. PubMed ID: 10694918
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in maple syrup urine disease: aspects of cofactor requirement and complementation in cultured fibroblasts.
Singh S; Willers I; Goedde HW
Clin Genet; 1977 Apr; 11(4):277-84. PubMed ID: 192504
[TBL] [Abstract][Full Text] [Related]
19. Molecular defects in the E1 alpha subunit of the branched-chain alpha-ketoacid dehydrogenase complex that cause maple syrup urine disease.
Zhang B; Zhao Y; Harris RA; Crabb DW
Mol Biol Med; 1991 Feb; 8(1):39-47. PubMed ID: 1943689
[TBL] [Abstract][Full Text] [Related]
20. Maple syrup urine disease. Complete primary structure of the E1 beta subunit of human branched chain alpha-ketoacid dehydrogenase complex deduced from the nucleotide sequence and a gene analysis of patients with this disease.
Nobukuni Y; Mitsubuchi H; Endo F; Akaboshi I; Asaka J; Matsuda I
J Clin Invest; 1990 Jul; 86(1):242-7. PubMed ID: 2365818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
